Supplier News

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

Famar, a contract development and manufacturing organization (CDMO), has appointed Bruno Biscaro as President, North America. In this role, Biscaro will lead all Famar’s business activities and operations within the region. Biscaro brings over 30...

Thermo Fisher Scientific and the University of Pittsburgh have established a new Pharmacogenomics (PGx) Center of Excellence that combines technology in genomics, bioinformatics, implementation science, medication-response phenotyping, and...

Therapure Biopharma, a Mississauga, Ontario, Canada-based biologics manufacturer, has launched its plasma products and technology division as Evolve Biologics, focused on plasma-derived therapeutics for patients with rare chronic diseases and acute...

AGC Biologics, a Bothell, Washington-headquartered contract development and manufacturing organization of biologics, plans to add a new building complex that will house the company’s global headquarters in Bothell. The new complex is located...

Abzena, a contract manufacturer of biologics and antibody drug conjugates, has completed a facility remodeling for a new antibody-drug conjugate (ADC) GMP manufacturing suite at its Bristol, Pennsylvania site. The facility is being equipped with...

Syngene International, a Biocon subsidiary and Bangalore, India-headquartered contract research organization, has reported on its recent developments and expansion plans. In January 2018, Syngene signed a multi-year development and manufacturing...

Rephine, a Stevenage, United Kingdom-headquartered provider of clinical and regulatory services to the pharmaceutical industry, has developed an active pharmaceutical ingredient (API) sourcing portal to streamline the API sourcing process for...

PCI Pharma Services, a Philadelphia, Pennsylvania-based pharmaceutical contract service provider, is investing in a laboratory expansion at its site in Tredegar, Wales, UK. The Tredegar facility is PCI’s center of excellence for development and...

Thermo Fisher Scientific plans to invest $35 million in a pharmaceutical services supply-chain facility in Rheinfelden (Baden) Germany. The new facility will increase capacity for cold and ambient clinical trial materials in support of clinical...

MedPharm, a Guildford, England-headquartered provider of formulation and development services for topical and transdermal products, has invested $75 million on automated instrumentation for its US facilities based in Durham, North Carolina. The...